Analgesia for people with acute ankle sprain
Intended for healthcare professionals
Art & Science Previous     Next

Analgesia for people with acute ankle sprain

David Carter Urgent care centre emergency care practitioner, West Middlesex University Hospital NHS Trust
Jeshni Amblum-Almer Senior lecturer-practitioner in primary care, Kingston and St George’s University, London

David Carter and Jeshni Amblum-Almer discuss the results of a literature review on using non-steroidal anti-inflammatory drugs in the management of a common injury

Around 302,000 people with soft-tissue ankle injuries present to UK emergency departments every year (Ferran and Maffulli 2006). These patients are generally treated conservatively with analgesia, ice, compression and elevation, and rest. There is some discussion in the literature about whether or not people with these injuries should be treated with non-steroidal anti-inflammatory drugs (NSAIDs), with some authors claiming that the inflammatory response following injury is part of the healing process and should not be halted. This article examines the literature on the efficacy of administering NSAIDs as the first-line drug management for ankle sprain. It also considers cost of treatment, prescribing practice and contraindications of NSAIDs.

Emergency Nurse. 23, 1, 24-31. doi: 10.7748/en.23.1.24.e1417


Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared

Received: 02 February 2015

Accepted: 16 March 2015

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now